Drug class
Methylene Blue
Rather than designating an entire therapeutic drug class, methylene blue is a specific synthetic active pharmaceutical ingredient that functions as an oxidation-reduction agent, an antidote, and a diagnostic dye. Read more about Methylene Blue
10 drugs in this class 9 manufacturers
Drugs in Methylene Blue
Rather than designating an entire therapeutic drug class, methylene blue is a specific synthetic active pharmaceutical ingredient that functions as an oxidation-reduction agent, an antidote, and a diagnostic dye.
Therapeutically, it is converted in erythrocytes to leucomethylene blue, which acts as an electron donor to reduce ferric iron back to the ferrous state, restoring the oxygen-carrying capacity of hemoglobin.
Its primary established medical indication is the treatment of acquired methemoglobinemia, alongside diagnostic visualization during surgical procedures and off-label critical-care applications such as refractory vasoplegic shock.
-
opss.org
Rather than designating an entire therapeutic drug class, methylene blue is a specific synthetic active pharmaceutical ingredient that functions as an oxidation-reduction agent, an antidote, and a diagnostic dye Its primary established medical indication is the treatment of acquired methemoglobinemia, alongside diagnostic visualization during surgical procedures and off-label critical-care applications such as refractory vasoplegic shock
-
drugs.com
Rather than designating an entire therapeutic drug class, methylene blue is a specific synthetic active pharmaceutical ingredient that functions as an oxidation-reduction agent, an antidote, and a diagnostic dye Therapeutically, it is converted in erythrocytes to leucomethylene blue, which acts as an electron donor to reduce ferric iron back to the ferrous state, restoring the oxygen-carrying capacity of hemoglobin Its primary established medical indication is the treatment of acquired methemogl...
-
nih.gov
Therapeutically, it is converted in erythrocytes to leucomethylene blue, which acts as an electron donor to reduce ferric iron back to the ferrous state, restoring the oxygen-carrying capacity of hemoglobin Its primary established medical indication is the treatment of acquired methemoglobinemia, alongside diagnostic visualization during surgical procedures and off-label critical-care applications such as refractory vasoplegic shock
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.